Navigation Links
EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
Date:6/2/2008

r, CEO of EnzySurge. "This latest funding round is a great vote of confidence from our investors. The funds will enable us to carry out plans to complete the transition from an R&D focused organization to the marketing and business development phase of our company. We are focused on the final steps in commercialization of our products, completing the regulatory process and preparing for market launch in early 2009."

Shiner adds: "We recently opened a US headquarter office in Virginia which will manage the US operations, with focus on a disciplined market launch, increasing market penetration, and establishing strategic partnerships. We have also recently completed a branding process and have launched our new Web site http://www.dermastream.com. We are experiencing a growing interest from leading players in the wound care market."

About EnzySurge

EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. EnzySurge's flagship DermaStream(TM) platform based on the proprietary Continuous Streaming Therapy (CST(TM)) offers a new and unique wound treatment modality by continuously streaming a fresh supply of advanced therapeutic solutions to a controlled wound environment. DermaStream(TM) is designed to deliver effective, affordable and easy-to-use wound treatment throughout all phases of chronic wound treatment from debridement, through regeneration to wound closure. DermaStream(TM) is intended for use in hospitals, clinics and for home care.

EnzySurge is committed to the development and delivery of innovative solutions that improve the quality of life of chronic-wound patients by shortening healing time, preventing hospitalization and reducing treatment costs. For more information, please visit our web site http://www.dermastream.com.

PR Contacts:

Boaz Gru
'/>"/>

SOURCE EnzySurge Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center
2. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
3. Ortho Evra Patch Makers Settling Cases
4. New research shows that iPods do not interfere with cardiac pacemakers
5. Bioscience Group Warns Policymakers Against Complacency
6. BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
7. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
8. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
9. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
10. BioMarin to Present at the BioCentury NewsMakers Conference
11. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)... NEW YORK, Nov. 18 Reportlinker.co...vailable in its catalogue. ,, Biotechnology R...tp://www.reportlinker.com/p0164375/Biotechnology-R...rce=prnewswire&utm_medium=pr&utm_campaign=...are complex chemical compounds used in a range of ...
(Date:11/18/2009)... Promega Corporation and SwitchGear Geno...A-protein interactions. , ...mega Corporation and SwitchGear Genomics announce ...ractions. Results of a study using the HaloCHIP&tr...monstrate the ability to correlate DNA binding eve...
(Date:11/18/2009)...111 significantly reduces key cardiac enzymes at m...esented at American Heart Association 2009 Scienti...e/ - Viron Therapeutics Inc., a biotechnology comp...g protein therapeutics derived from pathogens, tod...l evaluating VT-111 (Serp-1), an anti-inflammatory...
(Date:11/18/2009)...ALTIMORE, Nov. 18 Champ...R), an oncology drug development company with a pr...g the development and enhancing the value of oncol...agreement with Yale University and Southern Resear...cancer treatment. Scientists from Yale and Southe...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4
...on Statistical Considerations for Model, Selection...and Simulation Using M...t,Corporation (OTC Bulletin Board: PHST), a leadin...optimizing clinical drug development, today,announ...two presentations,to biopharmaceutical industry st...
... hospitals in,the north of England are implementin...system that enables them to function as one clinic...cology at hospitals in Lancashire and,Cumbria is e...fficiency by,fully integrating the prescribing, pr...for treating cancer. The network will include onc...
...ven a 39 day shelf life, according to scientists s...ciety for General Microbiologys 161st Meeting at t...6 September 2007. , Traditional cooked ham has a ...ays), including the time from processing to shoppe...tly cooked ham has 55% of the UK cooked meat marke...
Other Biology Technology:Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 3Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network 2Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network 3Cooked ham with a 39 day shelf life 2
(Date:11/20/2009)...a new study, researchers report that a class of he...lpful, or harmful, effect on the heart, depending ...appears in the journal Circulation Research , fou...and beta-receptors on the heart muscle offer the m...target only the beta-receptors can actually underm...
(Date:11/19/2009)...000 years ago, at the end of the last ice age, Nor...luding such iconic creatures as mammoths, mastodon... began their precipitous slide to extinction. , ...nd whose diversity of large animals equaled or sur...n or now, an entirely novel ecosystem emerged as b...
(Date:11/19/2009)...scientists are revealing the genetic instructions ...rn, or maize, has one of the most complex sequence...in-Madison genomicist David Schwartz, who was one ...rnal Science . , "The maize genome is a true ma...ave troubled would-be sequencers for years," says ...
Breaking Biology News(10 mins):Carvedilol shown to have unique characteristics among beta blockers 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Experts to Review Quality Improvement Programs to Prevent Preterm Birth 57668 1Experts to Review Quality Improvement Programs to Prevent Preterm Birth 57668 2Experts to Review Quality Improvement Programs to Prevent Preterm Birth 57668 3Inspector General Completes Study of VA Endoscopic Programs 57666 1Inspector General Completes Study of VA Endoscopic Programs 57666 2Ulcer Preventative May Raise Pneumonia Risks 57664 1Ulcer Preventative May Raise Pneumonia Risks 57664 2
...rge-scale analysis of proteins in the brains of in...covered novel proteins and mechanisms that may one...ion. , The results, reported in the current issue ...how differences in the amounts of 50 proteins and ...d to long-term cocaine use, said Scott E. Hemby, P...
...people are at greater risk of developing cancer as...shed today (June 2). , Scientists have discovered ...ct us from cancer may also determine how long we l...ected journal Science ?open up a new avenue of inq...We have discovered that proteins that prevent canc...
...ehensive analysis of an animal,s immune response t...nto the killer flu, report federally supported sci...e journal Nature. Key among these insights, they f...mune response that may contribute to the lethality... that it is the combination of all eight of the 19...
Other Biology News:High-tech research shows cocaine changes proteins and brain function 2Worm links cancer risk to ageing 2Mouse study reveals new clues about virulence of 1918 influenza virus 2Mouse study reveals new clues about virulence of 1918 influenza virus 3
Anti-Potassium Channel, Inward Rectifier Kir4.1 Polyclonal Antibody, Unconjugated from CHEMICON
... Development kit contains the basic components req...asure natural and recombinant mouse Dickkopf homol... Each kit contains sufficient materials to run ELI...ded that the following conditions are met: The as...
Goat Anti-HIV-1 TAT Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: